ArticleBritish journal of pharmacology2005

The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.

Damian Stephan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.